Almac, Genentech enter cancer collaboration

The Almac Discovery oncology subsidiary of Almac Group Ltd. (Craigavon, U.K.) granted the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY) development and commercialization rights to its preclinical ubiquitin-specific protease inhibitors. ...